Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPRG.L Regulatory News (PRG)

  • There is currently no data for PRG

Rule 8.3-Premier Research Gro

22 Apr 2008 14:19

Fidelity International Ltd22 April 2008 AVS Number: FORM 8.3 DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE (Rule 8.3 of the Takeover Code) 1. KEY INFORMATION Name of person dealing (Note 1) FMR LLC and/or one or more of its direct or indirect subsidiaries And Fidelity International Limited and/or one or more of its direct and indirect subsidiaries Company dealt in Premier Research Group Plc Class of relevant security to which the Ordinary Sharesdealings being disclosed relate (Note 2) Date of dealing 21-April-08 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class ofrelevant security dealt in (Note 3) Long Short Number (%) Number (%) (1) Relevant securities 7,268,334 (12.08%) (2) Derivatives (other than options) (3) Options and agreements to purchase/sell Total 7,268,334 (12.08%) (b) Interests and short positions in relevant securities of the company,other than the class dealt in (Note 3) Class of relevant security: Long Short Number (%) Number (%) (1) Relevant securities (2) Derivatives (other than options) (3) Options and agreements to purchase/sell Total (c) Rights to subscribe (Note 3) Class of relevant security: Details 3. DEALINGS (Note 4) (a) Purchases and sales Purchase/sale Number of securities Price per unit (Note 5) Sale 1,000,000 0.9600 GBP/ Share (b) Derivatives transactions (other than options) Product name, Long/short (Note 6) Number of securities (Note 7) Price per unit (Note 5)e.g. CFD (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Product name, Writing, selling, Number of securities Exercise Type, e.g. Expiry Option money purchasing, to which the option American,e.g. call option varying etc. relates (Note 7) price European etc. date paid/received per unit (Note 5) (ii) Exercising Product name, e.g. call option Number of securities Exercise price per unit (Note 5) (d) Other dealings (including new securities) (Note 4) Nature of transaction (Note 8) Details Price per unit (if applicable) (Note 5) 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the person disclosing and any other person relatingto the voting rights of any relevant securities under any option referred to on this form or relating to the votingrights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form isreferenced. If none, this should be stated. Is a Supplemental Form 8 attached? (Note 9) No Date of disclosure 22-April-08 Contact name Fabio Correia Telephone number 01737 837092 If a connected EFM, name of offeree/offeror with which connected N/A If a connected EFM, state nature of connection (Note 10) N/A Notes The Notes on Form 8.3 can be viewed on the Takeover Panel's website atwww.thetakeoverpanel.org.uk This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
31st Oct 20078:31 amRNSRule 8.3- Amendment
31st Oct 20078:31 amRNSRule 8.3 - Premier Research
31st Oct 20078:29 amRNSRule 8.3- Premier Research
31st Oct 20078:27 amRNSRule 8.3 - Premier Research
30th Oct 20079:32 amRNSEPT Disclosure
29th Oct 20073:40 pmRNSRule 8.3- (Premier Research)
29th Oct 20078:35 amRNSEPT Disclosure
26th Oct 200712:22 pmRNSRule 8.3- Premier Research Gp
26th Oct 200711:59 amRNSRule 8.3-Premier Research Gp
26th Oct 200710:07 amRNSEPT Disclosure
25th Oct 20073:32 pmRNSRule 8.3- Premier Research Gp
25th Oct 20078:37 amRNSEPT Disclosure
24th Oct 20072:00 pmRNSRule 8.3- Premier Research
24th Oct 20079:45 amRNSEPT Disclosure
23rd Oct 20073:01 pmRNSRule 8.3- Premier Research Gp
23rd Oct 20073:00 pmRNSRule 8.3- premier research
23rd Oct 200711:29 amRNSEPT Disclosure
22nd Oct 20079:07 amRNSEPT Disclosure
19th Oct 20073:26 pmRNSRule 8.3- (Premier Research)
19th Oct 200712:55 pmRNSInterim dividend-Amendment
19th Oct 200710:16 amRNSEPT Disclosure
19th Oct 20077:01 amRNSInterim Dividend
18th Oct 20073:14 pmRNSRule 8.3- Premier Research
18th Oct 20078:20 amRNSEPT Disclosure
18th Oct 20077:02 amRNSInterim Results
17th Oct 200710:08 amRNSEPT Disclosure
16th Oct 200710:23 amRNSEPT Disclosure
16th Oct 200710:11 amRNSNotification of Results
15th Oct 20072:50 pmRNSRule 8.3- Premier Research Gp
15th Oct 20078:57 amRNSEPT Disclosure
12th Oct 200710:59 amRNSRule 8.3- Premier Research Gp
12th Oct 20079:27 amRNSEPT Disclosure
11th Oct 200711:17 amRNSRule 8.3- Premier Research Gp
11th Oct 20079:35 amRNSEPT Disclosure
10th Oct 20072:23 pmRNSRule 8.3- PREMIER RESEARCH
9th Oct 20071:29 pmRNSRule 8.3- Premier Research Gp
9th Oct 20078:23 amRNSEPT Disclosure
8th Oct 20079:48 amRNSEPT Disclosure
5th Oct 200711:57 amRNSRule 8.3- Premier Research
5th Oct 200710:12 amRNSEPT Disclosure
4th Oct 20079:53 amRNSEPT Disclosure
3rd Oct 200712:55 pmRNSEPT Disclosure
2nd Oct 20079:53 amRNSEPT Disclosure
1st Oct 20078:18 amRNSEPT Disclosure
28th Sep 200711:04 amRNSRule 8.3- Premier Research
28th Sep 200710:25 amRNSEPT Disclosure
27th Sep 200712:01 pmRNSRule 8.3- Premier Research Gp
27th Sep 200710:25 amRNSRule 8.3-Premier Research Grp
27th Sep 20079:16 amRNSEPT Disclosure
26th Sep 20079:20 amRNSEPT Disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.